Search or
𝛼SK
𝛼SKbearish
Akeso Inc Placement - Another Opportunistic Raise, Mixed past Deal but Is Relatively Small
461 Views27 Aug 2025 19:05
Akeso Biopharma Inc (9926 HK) is looking to raise around US$460m from a mix of primary placement and selldown by its founders. In this note, we talk about the deal dynamics.
What is covered in the Full Insight:
- Introduction
- Deal Terms and Dynamics
- Recent Performance
- Framework Scores
- Concluding Thoughts
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Simcere Pharma Placement - First Primary Raising, past Deals Have Been Mixed01 Sep 2025
- Hansoh Pharma Placement - Somewhat Expected but Still Opportunistic19 Aug 2025
- Hong Kong 2025 Placements - Year so Far and Trends for Potential Primary Placements06 Aug 2025
- Akeso Placement - Opportunistic Raise, past Deal Record Has Been Mixed but Relative Size Is Small10 Oct 2024
x